Literature DB >> 12154071

Farnesylation of Cenp-F is required for G2/M progression and degradation after mitosis.

Deema Hussein1, Stephen S Taylor.   

Abstract

Farnesyl transferase inhibitors induce G2/M cell cycle delays that cannot be explained by inhibition of the Ras GTPase. Recently, the kinetochore protein Cenp-F has been shown to be farnesylated. Here, we show that ectopic expression of the kinetochore targeting domain of Cenp-F delays progression through G2/M. Significantly, this is dependent on the CAAX farnesylation motif. We also show that localisation of Cenp-F to the nuclear envelope at G2/M and kinetochores in prometaphase is dependent both on its CAAX motif and farnesyl transferase activity. Strikingly, farnesyl transferase activity is also required for Cenp-F degradation after mitosis. Thus, these observations suggest that farnesylation of Cenp-F is required not only for its localisation to the nuclear envelope and kinetochores but also for timely progression through G2/M and its degradation after mitosis. In addition, these observations raise the possibility that the anti-proliferative effects induced by farnesyl transferase inhibitors may be due to inhibition of Cenp-F function and/or turnover.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154071     DOI: 10.1242/jcs.115.17.3403

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  60 in total

Review 1.  Preclinical and clinical evaluation of farnesyltransferase inhibitors.

Authors:  Charles Baum; Paul Kirschmeier
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

Review 2.  The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation.

Authors:  Stephen S Taylor; Maria I F Scott; Andrew J Holland
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

3.  A novel function of Rab5 in mitosis.

Authors:  Letizia Lanzetti
Journal:  Small GTPases       Date:  2012-06-14

Review 4.  Regulatory mechanisms of kinetochore-microtubule interaction in mitosis.

Authors:  Kozo Tanaka
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

5.  CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

Authors:  Sallyann L O'Brien; Ailís Fagan; Edward J P Fox; Robert C Millikan; Aedín C Culhane; Donal J Brennan; Amanda H McCann; Shauna Hegarty; Siobhan Moyna; Michael J Duffy; Desmond G Higgins; Karin Jirström; Göran Landberg; William M Gallagher
Journal:  Int J Cancer       Date:  2007-04-01       Impact factor: 7.396

Review 6.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

7.  Murine CENP-F regulates centrosomal microtubule nucleation and interacts with Hook2 at the centrosome.

Authors:  Katherine L Moynihan; Ryan Pooley; Paul M Miller; Irina Kaverina; David M Bader
Journal:  Mol Biol Cell       Date:  2009-09-30       Impact factor: 4.138

8.  CAAX-box protein, prenylation process and carcinogenesis.

Authors:  Juehua Gao; Jie Liao; Guang-Yu Yang
Journal:  Am J Transl Res       Date:  2009-05-25       Impact factor: 4.060

9.  Cdc20 is required for the post-anaphase, KEN-dependent degradation of centromere protein F.

Authors:  Mark D J Gurden; Andrew J Holland; Wouter van Zon; Anthony Tighe; Mailys A Vergnolle; Douglas A Andres; H Peter Spielmann; Marcos Malumbres; Rob M F Wolthuis; Don W Cleveland; Stephen S Taylor
Journal:  J Cell Sci       Date:  2010-01-05       Impact factor: 5.285

10.  Murine CENPF interacts with syntaxin 4 in the regulation of vesicular transport.

Authors:  Ryan D Pooley; Katherine L Moynihan; Victor Soukoulis; Samyukta Reddy; Richard Francis; Cecilia Lo; Li-Jun Ma; David M Bader
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.